Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
RBD-4059 by Suzhou Ribo Life Sciences for Thromboembolism: Likelihood of Approval
RBD-4059 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Thromboembolism. According to GlobalData,...
RBD-7022 by Suzhou Ribo Life Sciences for Hyperlipidemia: Likelihood of Approval
RBD-7022 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Hyperlipidemia. According to GlobalData,...
RBD-5044 by Suzhou Ribo Life Sciences for Familial Chylomicronemia (Type I Hyperlipoproteinemia): Likelihood of Approval
RBD-5044 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Familial Chylomicronemia (Type I...
RBD-5044 by Suzhou Ribo Life Sciences for Hypertriglyceridemia: Likelihood of Approval
RBD-5044 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Hypertriglyceridemia. According to GlobalData,...